JPMorgan resumes Denali Therapeutics stock coverage with Overweight rating

JPMorgan resumes Denali Therapeutics stock coverage with Overweight rating

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.